Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drug resistance and implication for therapy].

T Tsuruo

    [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
    |August 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Cancer cells can develop resistance to chemotherapy, a complex issue impacting treatment effectiveness. Understanding cellular resistance mechanisms, particularly multidrug resistance, is key to developing new therapeutic strategies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis.

    Blood·2000
    Same author

    Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs.

    Cancer research·2000
    Same author

    Characterization of dihydropyrimidine dehydrogenase on immunohistochemistry in colon carcinoma, and correlation between immunohistochemical score and protein level or messenger RNA expression.

    Annals of oncology : official journal of the European Society for Medical Oncology·2000
    Same author

    Analysis of novel metastasis-associated gene TI-227.

    Japanese journal of cancer research : Gann·2000
    Same author

    Retinoblastoma susceptibility protein, Rb, possesses multiple BRCT-Ws, BRCA1 carboxyl-terminus-related W regions with DNA break-binding activity.

    Oncogene·2000
    Same author

    MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer.

    The oncologist·2000
    Same journal

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026
    Same journal

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026
    Same journal

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026
    Same journal

    [Recent advances in pathogenesis, diagnosis, and therapeutic strategies for POEMS syndrome].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026
    Same journal

    [Recent advances in management of systemic AL amyloidosis].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026
    Same journal

    [Treatment strategies for relapsed or refractory multiple myeloma: proposals for optimal treatment sequencing].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026
    See all related articles

    Area of Science:

    • Oncology
    • Molecular Biology
    • Pharmacology

    Background:

    • Drug resistance is a significant challenge in cancer chemotherapy, leading to treatment failure.
    • Tumor cells can acquire resistance to anticancer drugs, complicating patient outcomes.
    • Cellular resistance is now recognized as a critical factor in patient drug resistance.

    Purpose of the Study:

    • To describe the mechanisms of cellular resistance in cancer.
    • To elucidate the molecular basis of multidrug resistance.
    • To discuss strategies for overcoming drug resistance in cancer patients.

    Main Methods:

    • Application of cellular and molecular techniques.
    • Integration with traditional biological and biochemical methods.
    • Focus on molecular-level analysis of resistance mechanisms.

    Related Experiment Videos

    Main Results:

    • Detailed description of cellular resistance mechanisms.
    • Elucidation of multidrug resistance at the molecular level.
    • Identification of key pathways involved in drug resistance.

    Conclusions:

    • Understanding molecular mechanisms of drug resistance is crucial.
    • Multidrug resistance presents a complex challenge in cancer therapy.
    • Developing strategies to overcome resistance is essential for improving chemotherapy efficacy.